DTL reports 45% increase in year-end net profit attributable to shareholders

March 2, 2023

 

Revenue increased 4% to $18.42 billion (2021: $17.74 billion). For the quarter, trading income declined 17% to $4.61 billion (2021: $5.55 billion).

Cost of sales declined 4% to $13.78 billion (2021: $14.34 billion). Consequently, gross profit increased 36% to $4.64 billion (2021: $3.41 billion). For the quarter, gross profit increased 54% to $1.62 billion (2021: $1.05 billion).

Other operating income increased 128% to $237.37 million (2021: $103.89 million).

Total operating expenses increased 35% to $3.68 billion (2021: $2.73 billion). Of this, administrative expenses increased 29% to $3 billion (2021: $2.33 billion), while selling and distribution expenses increased 71% to $689.13 million (2021: $402.29 million).

Operating profit increased 51% to $1.19 billion (2021: $787.04 million). For the quarter, operating profit increased 65% to $397.47 million (2021: $241.57 million).

Finance costs increased 100% to $463.58 million (2021: $231.32 million).

Profit before taxation increased 31% to $726.05 million (2021: $555.72 million). For the quarter, profit before taxation increased 121% to $200.81 million (2021: $90.77 million).

After incurring tax charges of $108.42 million (2021: $107.54 million), net profit increased 38% to $617.63 million (2021: $448.18 million).

Net profit attributable to shareholders increased 45% to $579.98 million (2021: $399.94 million).

Earnings per share (EPS) amounted to $0.128 (2021: $0.088). The total number of shares used in the computation amounted to 4,533,360,670 units. Notably, DTL closed the trading period on March 1, 2023 at a price of $2.14 with a corresponding P/E of 16.49 times.

Balance Sheet Highlights:

Total assets increased 33% to $15.37 billion (2021: $11.55 billion). This was largely due to increases in ‘Fixed Assets’ and ‘Inventories’ which closed at $3.75 billion (2021: $2.35 billion) and $4.15 billion (2021: $2.68 million), respectively.

Total shareholders’ equity increased 10% to $6.13 billion (2021: $5.55 billion), which translated to a book value of $1.35 (2021: $1.23).

 

Disclaimer: 

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…